Industry Workshop by GE HealthCare

IWS 79 - Diagnostic performance of Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of hepatic steatosis in patients with biopsy-proven non-alcoholic fatty liver disease: a prospective study

March 2, 11:15 - 12:00 CET

Industry Workshop by GE HealthCare
Tommaso Vincenzo Bartolotta, None / Italy
In this workshop, Prof Tommaso Bartolotta will share the results of the prospective study conducted at his Institute to validate the accuracy of UGAP, non-invasive technique, to stage liver steatosis in comparison to biopsy. The format of the session will favour an open discussion and live hands on.
Sign up here

This workshop will not be streamed, nor will it be available on-demand!